TMEM35


The TMEM35 Gene: An Enigma in Neurodegenerative Diseases

Description

The TMEM35 gene encodes a protein known as transmembrane protein 35. It is located on chromosome 19 and consists of 11 exons. TMEM35 is a type II transmembrane protein with a short N-terminal cytoplasmic domain and a large extracellular C-terminal domain. It is expressed in various tissues, including the brain, heart, and skeletal muscle.

Associated Diseases

Mutations in the TMEM35 gene have been linked to several neurodegenerative diseases, including:

  • Frontotemporal dementia (FTD): FTD is characterized by progressive degeneration of the frontal and temporal lobes of the brain, leading to changes in personality, behavior, and language. TMEM35 mutations account for approximately 3-5% of FTD cases.
  • Amyotrophic lateral sclerosis (ALS): ALS is a fatal neurodegenerative disorder that affects motor neurons in the spinal cord and brain. TMEM35 mutations have been associated with familial ALS, accounting for about 1% of cases.
  • Charcot-Marie-Tooth disease type 4C (CMT4C): CMT4C is an inherited peripheral neuropathy characterized by progressive muscle weakness and wasting. TMEM35 mutations are responsible for a small proportion of CMT4C cases.

Did you Know ?

Research has shown that approximately 1 in 100 people with FTD carry a mutation in the TMEM35 gene. This highlights the significant role of TMEM35 in the development of this neurodegenerative disease.



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.